ResearchMoz

Implantable Medical Devices Market (Reconstructive Joint Replacement, Spinal Implants, Cardiovascular Implants, Dental Implants, Intraocular Lens And Breast Implants) - U.S. Industry Analysis, Size, Share, Trends, Growth And Forecast, 2012 - 2018

Transparency Market Research
Published Date » 2013-01-23
No. Of Pages » 98
 
 
   
 This report covers major aspects of the U.S.  implantable  medical devices market. It covers the performance of the major types of implantable devices in terms of their revenue, and the market is classified according to the number of procedures performed. The overall implantable medical devices market is classified as orthopedic implants, cardiovascular implants and other (dental,  intraocular  lens and breast) implants market. The report also provides extensive analysis of the sub-segments of the market considering 2011 as the base year for market size calculations and forecast from 2012 to 2018. 
   
 The orthopedic  implants  market is classified on the basis of types of orthopedic implants and orthopedic implantation procedures. The analysis covers the estimated...
Table of Content:

Chapter1Preface
1.1ResearchScopeAndDescription
1.2Research Methodology

Chapter2ExecutiveSummary

Chapter3U.S.ImplantableMedicalDevicesMarketAnalysis
3.1Introduction
3.1.1MarketEnvironment
3.1.2PolicyIssues
3.1.3U.S.KeyIndicatorsForImplantableMedicalDevices
3.2MarketDrivers
3.2.1 HighIncidenceOfChronicDegenerativeDiseases
3.2.2IncreaseInAgingPopulation
3.2.3RiseInPurchasingParityAndIncreaseInHealthcareExpenditure
3.3MarketRestraints
3.3.1HighPriceOfImplantableDevices
3.4MarketOpportunities
3.4.1TechnicalInnovation
3.5Porter’sFiveForcesAnalysis
3.5.1BargainingPowerOfBuyers
3.5.2BargainingPowerOfSuppliers
3.5.3ThreatOfSubstitutes
3.5.4ThreatOfNewEntrants
3.5.5CompetitiveRivalry
3.6MarketAttractivenessAnalysis
3.6.1U.S.ImplantableMedicalDevicesMarket,MarketAttractivenessAnalysis,2011

Chapter4U.S.ImplantableMedicalDevicesMarket,ProductSegmentation
4.1Overview
4.1.1CurrentScenario
4.1.1.1U.S.ImplantableMedicalDevicesMarket–TrendsandForecast,2010-2018(USDMillion)
4.1.2U.S.OrthopedicImplantsMarket
4.1.2.1Currentscenario
4.1.2.2ReconstructiveJointReplacements
4.1.2.2.1U.S.ReconstructiveJointReplacementMarket–TrendsandForecast,2010–2018(USDMillion)
4.1.2.3SpinalImplants
4.1.2.3.1U.S.SpinalImplantsMarket–TrendsandForecast,2010–2018(USDMillion)
4.1.2.4Orthobiologics
4.1.2.5Traumafixationimplants
4.1.2.6OtherImplants
4.1.3CardiovascularImplants
4.1.3.1U.S.CardiovascularImplantsMarket–TrendsandForecast,2010–2018(USDMillion)
4.1.3.2PacingDevices
4.1.3.3StructuralCardiacDevices
4.1.3.4CardiacStents
4.1.4DentalImplants
4.1.4.1U.S.DentalImplantsMarket–TrendsandForecast,2010–2018(USDMillion)
4.1.5IntraocularLens(Iols)
4.1.5.1U.S.IntraocularLensMarket–TrendsandForecast,2010–2018(USDMillion)
4.1.6BreastImplants
4.1.6.1U.S.BreastImplantsMarket–TrendsandForecast,2010–2018(USDMillion)
4.1.7OtherImplants
4.1.7.1U.S.OtherImplantableMedicalDevicesMarket,TrendsandForecast,2010–2018(USDMillion)

Chapter5U.S.ImplantableMedicalDevicesMarket,ByProcedures
5.1Overview
5.2U.S.OrthopedicImplantProcedures–TrendsAndForecast,2010–2018
5.2.1U.S.OrthopedicImplantProceduresMarket,2010–2018
5.2.2KneeReplacements
5.2.3SpinalFusionAndFixation
5.2.3.1U.S.SpinalFusionandFixationProceduresMarket,TrendandForecast,2010-2018
5.2.4FractureRepairProcedures
5.3U.S.CardiovascularImplantProcedures–TrendsAndForecast,2010–2018
5.3.1U.S.CardiovascularImplantProceduresMarket,2010–2018
5.3.2StentingProcedures
5.3.2.1U.S.StentingProceduresMarket,TrendandForecast,2010–2018
5.3.3DefibrillatorImplantation
5.3.3.1U.S.DefibrillatorImplantationProceduresMarket,TrendAndForecast,2010–2018
5.4U.S.OtherImplantProcedures–TrendsAndForecast,2010–2018
5.4.1IntraocularLensImplantProcedures
5.4.2BreastAugmentation
5.4.2.1U.S.BreastAugmentationProceduresMarket,TrendandForecast,2010–2018

Chapter6CompetitiveLandscapeAndRecommendations
6.1MarketShareAnalysisOfKeyPlayers,2011
6.1MarketStrategyForSuccess
6.2BarriersToBeConsidered

Chapter7CompanyProfiles
7.1AbbottLaboratories
7.1.1CompanyOverview
7.1.2FinancialOverview
7.1.3SwotAnalysis
7.1.4ProductPortfolio
7.1.1StrategicDevelopments
7.1.1.1BusinessDiversification
7.1.1.2R&DInitiatives
7.1.1.3InvestingInEmergingMarkets
7.1.2RecentDevelopments
7.2AlconLaboratories
7.2.1CompanyOverview
7.2.2FinancialOverview
7.2.3SwotAnalysis
7.2.4ProductPortfolio
7.2.5RecentDevelopments
7.3BiometIncorporated
7.3.1CompanyOverview
7.3.2FinancialOverview
7.3.3SwotAnalysis
7.3.4StrategicDevelopments
7.3.4.1Mergers,AcquisitionsAndTakeovers
7.3.5RecentDevelopments
7.4BauschAndLombIncorporated
7.4.1CompanyOverview
7.4.2SwotAnalysis
7.4.3StrategicDevelopments
7.4.3.1Mergers,AcquisitionsAndTakeovers
7.4.3.2NewProductLaunches
7.4.4RecentDevelopments
7.5BostonScientificCorporation
7.5.1CompanyOverview
7.5.2FinancialOverview
7.5.3SwotAnalysis
7.5.4StrategicDevelopments
7.5.4.1Mergers,AcquisitionsAndTakeovers
7.5.4.2NewProductApprovals
7.5.5RecentDevelopments
7.6JohnsonAndJohnson
7.6.1CompanyOverview
7.6.2FinancialOverview
7.6.3SwotAnalysis
7.6.4StrategicDevelopments
7.6.4.1Mergers,AcquisitionsAndTakeovers
7.6.4.2NewProductApprovalsAndLaunch
7.6.5RecentDevelopments
7.7MedtronicIncorporated
7.7.1CompanyOverview
7.7.2FinancialOverview
7.7.3SwotAnalysis
7.7.4ProductPortfolio
7.7.5StrategicDevelopments
7.7.6RecentDevelopments
7.8St.JudeMedicalIncorporated
7.8.1CompanyOverview
7.8.2FinancialOverview
7.8.3SwotAnalysis
7.8.4StrategicDevelopments
7.8.4.1SignificantR&DInvestmentsForNewProductDevelopment
7.8.4.2MergersAndAcquisitions
7.8.5RecentDevelopments
7.9SmithAndNephewPlc
7.9.1CompanyOverview
7.9.2FinancialOverview
7.9.3SwotAnalysis
7.9.4StrategicDevelopments
7.9.4.1Mergers,AcquisitionsAndTakeovers
7.9.5RecentDevelopments
7.10StrykerCorporation
7.10.1CompanyOverview
7.10.2FinancialOverview
7.10.3SwotAnalysis
7.10.4StrategicDevelopments
7.10.4.1Mergers,AcquisitionsAndTakeovers
7.10.5RecentDevelopments
7.11SynthesIncorporated
7.11.1CompanyOverview
7.11.2FinancialOverview
7.11.3SwotAnalysis
7.11.4StrategicDevelopments
7.11.5RecentDevelopments
7.12ZimmerHoldingsIncorporated
7.12.1CompanyOverview
7.12.2FinancialOverview
7.12.3SwotAnalysis
7.12.4StrategicDevelopments
7.12.5RecentDevelopments

List of Tables


Table 1 The U.S. Implantable Medical Devices Market: Snapshot

List of Figures


fig. 1 U.S. Implantable Medical Devices Market, By Types Of Implants, 2011 (Usd Million)
Fig. 2 Porter’s Five Forces Analysis For The U.S. Implantable Medical Devices Market
Fig. 3 U.S. Implantable Medical Devices Market Attractiveness Analysis, 2011
Fig. 4 U.S. Implantable Medical Devices Market, 2010 – 2018 (Usd Million)
Fig. 5 U.S. Orthopedic Implants Market, 2010 – 2018 (Usd Million)
Fig. 6 U.S. Reconstructive Joint Replacement Market, 2010 – 2018 (Usd Million)
Fig. 7 U.S. Spinal Implants Market, 2010 – 2018 (Usd Million)
Fig. 8 U.S. Cardiovascular Implants Market, 2010 – 2018 (Usd Million)
Fig. 9 U.S. Dental Implants Market, 2010 – 2018 (Usd Million)
Fig. 10 U.S. Intraocular Lens Market, 2010 – 2018 (Usd Million)
Fig. 11 U.S. Breast Implants Market, 2010 – 2018 (Usd Million)
Fig. 12 U.S. Other Implantable Medical Devices Market, 2010 – 2018 (Usd Million)
Fig. 13 U.S. OrthopedicImplants Procedures Market, 2010 – 2018 (Million)
Fig. 14 U.S. Spinal Fusion And Fixation Procedures Market, 2010 – 2018 (Million)
Fig. 15 U.S. Cardiovascular Implant Procedures Market, 2010 – 2018 (Million)
Fig. 16 U.S. Stenting Procedures Market, 2010 – 2018 (Million)
Fig. 17 U.S. Defibrillator Implantation Procedures Market, 2010 – 2018 (Million)
Fig. 18 U.S. Breast Augmentation Procedures Market, 2010 – 2018 (Million)
Fig. 19 Abbott Laboratories: Net Sales, 2009 – 2011 (Usd Million)
Fig. 20 Alcon Laboratories: Net Sales, 2009 – 2011 (Usd Million)
Fig. 21 Biomet Incorporated: Net Sales, 2009 – 2011 (Usd Million)
Fig. 22 Boston Scientific: Net Sales, 2009 – 2011 (Usd Million)
Fig. 23 Johnson & Johnson: Net Sales, 2009 – 2011 (Usd Million)
Fig. 24 Medtronic Inc: Net Sales, 2009 – 2011 (Usd Million)
Fig. 25 St Jude Medical Inc.: Net Sales, 2009 – 2011 (Usd Million)
Fig. 26 Smith And Nephew Plc: Net Sales, 2009 – 2011 (Usd Million)
Fig. 27 Stryker Corporation: Net Sales, 2009 – 2011 (Usd Million)
Fig. 28 Synthes Corporation: Net Sales, 2009 – 2011 (Usd Million)
Fig. 29 Zimmer Holdings Inc.: Net Sales, 2009 – 2011 (Usd Million)

Upcoming Reports:

Amyotrophic Lateral Sclerosis Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
By - Transparency Market Research
Amyotrophic lateral sclerosis (ALS) is a neurological disease and also termed as Lou Gehrig’s disease.  The disease affects the motor neurons, which control the action of voluntary muscles, as a result the messages between brain and muscle fibers are blocked. ALS could occur in a person due to genetic inheritance, mutation in gene which encodes enzyme copper-zinc superoxide dismutase coupled with defect in chromosome 9. This disease is more prevalent in males. All these abnormalities results in the release of glutamate which damage the motor neurons controlling voluntary...
Bio-based & Low-VOC Paints Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
By - Transparency Market Research
VOCs (volatile organic compounds) are substances such as formaldehyde which are used in paints to allow them to dry faster. These are highly toxic to humans and high levels of VOC in paints results in the release of toxic VOC fumes for a long period of time. Low VOC paints use water as a solvent instead of petroleum-based materials. Bio-based paints use raw materials derived from natural sources such as plants and natural minerals which include plant oils, plant dyes, essential oils, clay, beeswax, mineral dyes, and talcum among others. Bio-based and low-VOC paints embed low VOC...
Alkyl Polyglucosides Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast 2014 - 2020
By - Transparency Market Research
Alkyl polyglucosides are bio surfactants produced by reacting of sugar with fat. Alkyl polyglucosides are non ionic surfactants and are among the recently developed high efficiency bio surfactants. Production process involves one step or two step process; butanol is used to produce butyl glucoside which is then reacted with fatty alcohol in the two step process. Corn starch and fatty alcohol are among the major raw material sources employed in the one step process. One step process is the dominant process used in the production of alkyl polyglucosides. Major application segments for alkyl...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.us
Select License type:

Share this report

Related News

Bolivian Air Force Receives the Super Puma Helicopters
Dec 16, 2014  
It was declared by the Airbus Helicopters that the Bolivian Air Force was the recipient of second of the six Airbus AS332 C1e Super Puma helicopters. The Super Pumas are generally used for several internal security missions and counter narcotics. The rest of the four helicopters will start operating from the year 2016. In late 2013, the light medium helicopters were purchased by the FAB for...
Leaked Emails Prove to be Challenging for Sony
Dec 15, 2014  
It has been revealed via leaked emails that there exists a cultural gulf between Sony Pictures Entertainment, the Hollywood subsidiary on the one hand and Japan’s Sony Corp on the other. This poses a major challenge to the CEO Kazuo Hirai to bring about positive changes in the loss making company under the One Sony slogan.  Over the past six years, this has been the fifth...
British Construction Firms to Hire More by 2015
Dec 10, 2014  
As per the latest survey carried out by Manpower, increasing workload in Britain’s construction industry is calling for rise in employment opportunities. It is expected that in the coming year, various construction firms will be on a hiring spree. Paucity of trained and skilled workers in U.K. based building firms has led to greater focus on hiring of Portuguese bricklayers at a wage...
Defense Workers Start a 10-Day Strike over Pay
Dec 8, 2014  
Members of Unite at the Defense Support Group are going to walk out on Monday protesting at a 1% pay offer. The group keeps repairing and renovating military equipment for the Ministry of Defense.  The Unite national officer, Mr. Mike McCartney, stated that Defense Support Group was cash-rich and asked them to take up negotiations for a fair pay deal again. The Ministry of Defense...
Record US$100 Mn Donated to the University of North Carolina for Pharmacy School
Dec 4, 2014  
The “Innovation Engine” received a US$100 million fund in the effort to create innovation at the UNC Eshelman School of Pharmacy, reported Chapel Hill, The University of North Carolina on Wednesday.  The donation is contributed from a 1972 graduate - Fred Eshelman who is also the founder of the Pharmaceutical Product Development and Furiex Pharmaceuticals. The money is...